This article is from the Childhood Vaccinations FAQ, by Lynn Gazis-Sax lynng@alsirat.com with numerous contributions by others.
*************************************************************************
From the April 1995 issue of Medical Sciences Bulletin, published by
Pharmaceutical Information Associates (pialtd@ix.netcom.com) and
available by Email subscription as MSB-L.
Use of Varivax is contraindicated for patients who are hypersensitive
to any component of the vaccine; those with a history of anaphylactoid
reaction to neomycin; those with active febrile infections, pregnancy,
blood dyscrasias or other malignancies, or primary or acquired
immunodeficiency; and those undergoing immunosuppressive therapy.
*************************************************************************
The July 12, 1996 ACIP recommendation lists, for the most part, the
same groups, but adds people who have experienced an anaphylactoid
reaction to gelatin, and people who have a family history of
congenital or hereditary immune deficiency in parents or siblings
(unless their own immune competence has been clinically substantiated
or confirmed by a laboratory). Pregnant women should not be
vaccinated, as the effect on the fetus is unknown.
Although no adverse reactions from taking aspirin after the vaccine
have been reported, it is recommended that people receiving the
varicella vaccine refrain from taking aspirin for 6 weeks afterwards,
because of the association between aspirin and Reyes syndrome
following varicella.
 
Continue to: